Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00460 SIHUAN PHARM
RTNominal up0.540 +0.010 (+1.887%)
Others

04/09/2017 08:50

Sihuan Pharma (00460) to invest in PharmaDax's subsidiary

[ET Net News Agency, 4 September 2017] Sihuan Pharmaceutical (00460) said the Group
will invest in PharmaDax (FoShan) Co., Ltd a subsidiary of the PharmaDax Inc., in phases.
In the first phase, the Group will subscribe for 19.99% equity interests in and
corporate bonds issued by, PharmaDax Foshan at Rmb200 million. Upon satisfaction of
conditions stipulated in the agreements, the Group will make an additional investment of
maximum Rmb200 million and convert the aforementioned corporate bonds into further equity
interests, and will hold a maximum of 51% equity interests in PharmaDax Foshan in
aggregate.
The PharmaDax Foshan owns advanced drug production technique and normative drug quality
control system that meets the United States Food and Drug Administration requirements. It
primarily focuses on the manufacturing of generic drugs with significant market size or
drugs of extended release formulation with challenging formulation design and few
competitors. Through the investment in PharmaDax Foshan, the Group expects to accelerate
its generic drug R&D and enhance the Group's overall competitiveness. (HL)

Remark: Real time quote last updated: 19/09/2024 15:56
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.